Letícia Pena Braga, PhD.

Department of Social Pharmacy , Federal University of Minas Gerais, Brazil

Poster(s):

• (C-225) Adverse events of treatment and characteristics of patients with multiple myeloma: a Brazilian historical cohort study
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (A-269) Disproportionality analysis of reports of HIV resistance to integrase strand-transfer inhibitors from the WHO global safety database
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-268) Disproportionality analysis of sexual dysfunction reports related to integrase strand-transfer inhibitors: data from the FDA Adverse Reporting System - FAERS
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-024) Evaluating Clinical Benefit and Regulatory Approval Patterns of Newly Approved Therapies for Multiple Myeloma: Is Brazil Keeping Pace with Global Advances?
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET